Eurofins Scientific SE
OTC: ERFSF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Gilles G. Martin
- Employees
- 62,696
- Headquarters
- Luxembourg City, Luxembourg
- IPO year
- 2010
- Market cap
- $13.2B
- Website
- https://www.eurofins.com
Loading ERFSF…
Loading profile data…Frequently asked questions about ERFSF
What does Eurofins Scientific SE (ERFSF) do?
Eurofins Scientific SE, along with its affiliated companies, delivers a broad spectrum of analytical testing and laboratory solutions globally. The firm utilizes an extensive repertoire of approximately 200,000 analytical techniques, designed to assess various product attributes such as safety, identification, makeup, genuineness, source, tracka...
Where does ERFSF trade?
Eurofins Scientific SE (ERFSF) trades on the Other OTC.
What sector is ERFSF in?
Eurofins Scientific SE (ERFSF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Eurofins Scientific SE?
Gilles G. Martin is the chief executive officer of Eurofins Scientific SE (ERFSF).
Where is Eurofins Scientific SE headquartered?
Eurofins Scientific SE is headquartered in Luxembourg.
Does ERFSF pay a dividend?
Yes — Eurofins Scientific SE (ERFSF) paid a trailing twelve-month dividend of USD 0.84 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ERFSF go public?
Eurofins Scientific SE (ERFSF) completed its initial public offering in 2010.